Compound I was identified as a novel allosteric inhibitor of Enzyme X.  The measured inhibitor dissociation constant Ki between the inhibitor and Enzyme X was found to be 54 μM without any substrate present.  With saturating amounts of nonreactive substrate analog, the measured Ki was found to be 76 μM.  Compound I is best described as:A.a mixed inhibitor that results in a lower apparent Km relative to the uninhibited enzyme.B.a mixed inhibitor that results in the same apparent Km relative to the uninhibited enzyme.C.a mixed inhibitor that results in a higher apparent Km relative to the uninhibited enzyme.D.a purely noncompetitive inhibitor that only lowers the apparent Vmax relative to the uninhibited enzyme.

The key to answering this question lies in understanding the properties of different types of enzyme inhibitors.

A mixed inhibitor can bind to the enzyme whether or not the substrate has already bound to the enzyme, and it has different affinities for these two forms of the enzyme. This is reflected in the different Ki values given in the question for Compound I with and without substrate present.

The effect of a mixed inhibitor on Km (the Michaelis constant, which is a measure of the affinity of the enzyme for its substrate) depends on whether it has a higher affinity for the enzyme-substrate complex or for the enzyme alone. If it has a higher affinity for the enzyme-substrate complex, it will increase the apparent Km. If it has a higher affinity for the enzyme alone, it will decrease the apparent Km.

In this case, the Ki of Compound I is higher when substrate is present, indicating that it has a lower affinity for the enzyme-substrate complex. Therefore, it will decrease the apparent Km.

So, the correct answer is A: Compound I is a mixed inhibitor that results in a lower apparent Km relative to the uninhibited enzyme.